An official website of the United States government

Publication Information

PubMed ID
Public Release Type
Journal
Publication Year
2021
Affiliation
Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.; Hepatology Division, Baylor Scott and White Medical Center, Dallas, TX.; Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.; UNC Liver Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Epidemiology and Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.; Liver Diseases Branch, NIDDK, NIH, Bethesda, MD.; Department of Medicine, Division of Gastroenterology and Hepatology, University of California San Francisco, San Francisco, CA.; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.; Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond, VA.; Division of Gastrointestinal and Liver Diseases, Keck Medicine of University of Southern California, Los Angeles, CA.; Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, ON, Canada.; Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO.; Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolois, MN.; Toronto Centre for Liver Disease, University of Toronto, Toronto, ON, Canada.
Authors
Lok Anna S., Perrillo Robert, Lalama Christina M., Fried Michael W., Belle Steven H., Ghany Marc G., Khalili Mandana, Fontana Robert J., Sterling Richard K., Terrault Norah, Feld Jordan J., Di Bisceglie Adrian M., Lau Daryl T.Y., Hassan Mohamed, Janssen Harry L.A.

Abstract

Outcomes of persons with chronic hepatitis B virus (HBV) infection in the era of antiviral therapy (AVT) are not well characterized. We determined the incidence and factors associated with clinical outcomes in a multiethnic, North American cohort of adults with chronic HBV infection, who were not on AVT at enrollment.